The Oncology Institute, Inc.

NASDAQ:TOI

Medical - Care Facilities

Healthcare
$5.13 -1.40%

-$0.07 today

Market cap
$512.91M
Beta
0.41
P/E (TTM)
-121.1
EPS (TTM)
-$0.04
52W Low $2.02High $5.58

Volume 1.21M

Average 1.74M

TOI Operating Expenses

Total costs of running the business that are not directly tied to producing goods or services sold.

The Oncology Institute, Inc.NASDAQ: TOI

Operating Expenses · Q1 FY2026 · quarter ended Mar 2026

Operating expenses grows in line with its trailing trend

Q1 FY2026 operating expenses of $28.21M rose 3.9% year over year, ahead of the +2.0% change in trailing-twelve-month operating expenses. Sequentially, it fell 4.9% from the prior quarter. Over 3 fiscal years it compounded at -5.7% a year.

Context

  • Operating expenses amounted to 22.4% of revenue in FY2025, down 6.6 pp from a year earlier.
  • Operating expenses increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +3.9% holds above the trailing-twelve-month pace of +2.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$28.21M-4.9% QoQ
Last fiscal yearDec 2025
$112.52M-1.4% YoY
LTMMar 2026
$113.57M+2.0% YoY
Operating Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+3.9%——
1 year-1.4%——
3-year CAGR-5.7%——
5-year CAGR——
10-year CAGR——

Operating Expenses history

USD · from the income statement

Latest · FY2025
112.52M USD
Year-over-year change
-1.4%
4-year CAGR
+6.7%

Operating Expenses vs competitors

How TOI compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +2.0% is the 4th highest of 10, against a peer median of -0.4%.
  • Operating expenses amounts to 20.8% of revenue for TOI, versus a peer median of 75.1%.
TOI Competitors
Operating Expenses for TOI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
AUNAAuna S.A.LTM Mar 2026PEN 1.08B PEN+10.7%+17.5%23.8%
AUTLAutolus Therapeutics plcLTM Mar 2026$254.35M USD-11.1%+20.4%274.7%
AGLAgilon Health, Inc.LTM Mar 2026$233.46M USD-18.8%+2.4%4.0%
EOLSEvolus, Inc.LTM Mar 2026$226.67M USD-0.4%+14.1%75.1%
TMCITreace Medical Concepts, Inc.LTM Mar 2026$221.01M USD-0.2%+14.5%106.6%
CCRNCross Country Healthcare, Inc.LTM Mar 2026$219.72M USD-20.5%-17.3%21.9%
KIDSOrthoPediatrics Corp.LTM Mar 2026$207.15M USD+8.5%+20.2%85.1%
CBLLCeriBell, Inc.LTM Mar 2026$148.33M USD+38.0%+33.4%156.0%
TOIThe Oncology Institute, Inc.LTM Mar 2026$113.57M USD+2.0%-5.7%20.8%
SNDASonida Senior Living, Inc.LTM Mar 2026-$38.53M USD-111.0%-51.3%9.4%
Peer median (excluding TOI) —-0.4%+14.5%75.1%

Competitors are the stored peer set for TOI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue203M252.48M324.24M393.41M502.73M
Cost of Revenue162.16M200.39M264.67M339.42M426.29M
Gross Profit40.85M52.09M59.57M54M76.44M
Gross Margin20.1%20.6%18.4%13.7%15.2%
Research & Development00000
Selling, General & Admin0000105.57M
Operating Expenses86.71M134.04M136.59M114.12M112.52M
Depreciation & Amortization3.34M4.41M5.87M6.29M6.94M
EBITDA(42.04M)(67.6M)(54.28M)(50.88M)(42.52M)
EBITDA Margin-20.7%-26.8%-16.7%-12.9%-8.5%
Operating Income(45.86M)(81.95M)(77.02M)(60.12M)(36.08M)
Operating Margin-22.6%-32.5%-23.8%-15.3%-7.2%
Interest Income00000
Interest Expense320K4.08M6.78M7.5M11.28M
Other Income / Expenses34.26M81.86M(6.09M)(4.55M)(24.65M)
Income Before Tax(11.6M)(91K)(83.1M)(64.66M)(60.74M)
Pre-Tax Margin-5.7%-0.0%-25.6%-16.4%-12.1%
Income Tax Expense(671K)(243K)(36K)0(131K)
Net Income(10.93M)152K(83.07M)(64.66M)(60.61M)
Net Margin-5.4%0.1%-25.6%-16.4%-12.1%
EPS (Basic)(0.16)0.00(0.92)(0.71)(0.54)
EPS (Diluted)(0.16)(0.21)(0.92)(0.71)(0.54)
Weighted Avg Shares66.23M72.79M73.75M75.04M923.89M
Weighted Avg Shares (Diluted)66.23M80.61M73.75M75.04M923.89M

The Oncology Institute, Inc.

NASDAQ:TOI

Intrinsic Alpha fair value

Locked

Current Price

$5.13

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.